We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Fluidigm Announce Israeli Distribution Deal

Read time: Less than a minute

Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm's complete portfolio of BioMark™, EP1™, and Access Array™ Systems and the complete line up of Dynamic Array™, Digital Array™ and Access Array IFCs for real-time PCR, digital PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing.

Eisenberg Brothers has a 50-year history in providing high end genetic analysis solutions to research organizations and businesses.

"This exciting partnership with Fluidigm will provide the scientific communities in Israel with powerful genomic tools backed by outstanding support," noted Amos Grundwag, Manager of the Genomics and Bio Informatics lines at Eisenberg Brothers. "We are happy to add Fluidigm to our portfolio of world leading suppliers. We recognize Fluidigm to be a great solution for a wide range of biological challenges that the scientific community is currently handling."

"Fluidigm is committed to bringing the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in Israel," said Dominique Remy-Renou, Vice President of European Sales and Support and General Manager of Fluidigm Europe BV.

Remy-Renou continued, "Eisenberg Brothers has built a reputation of addressing the needs of Israel's life sciences research community and we look forward to helping bring the tools needed to solve some of today's most complex genetic questions in biology all the way down to the single cell."